Nikolas Herold
Herold, Nikolas 1985-
VIAF ID: 315955408 (Personal)
Permalink: http://viaf.org/viaf/315955408
Preferred Forms
- 100 1 _ ‡a Herold, Nikolas ‡d 1985-
- 100 0 _ ‡a Nikolas Herold
4xx's: Alternate Name Forms (3)
5xx's: Related Names (4)
- 510 2 _ ‡a Goethe-Universität Frankfurt am Main ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Karolinska Institutet ‡g Stockholm ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Stuttgart- Bad Cannstatt ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Universität Heidelberg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors | |
The Early Bird Catches the Worm--Can Evolution Teach us Lessons in Fighting HIV? | |
Effects of inner nuclear membrane proteins SUN1/UNC-84A and SUN2/UNC-84B on the early steps of HIV-1 infection | |
Entry of human immunodeficiency virus type 1 in T-cells | |
Evidence for SAMHD1 Tumor Suppressor Functions in Acute Myeloid Leukemia | |
HIV-1 entry in SupT1-R5, CEM-ss, and primary CD4+ T cells occurs at the plasma membrane and does not require endocytosis. | |
Improved Local Control by Extensive Surgery in High-Risk Neuroblastoma May Be Dependent on Adjuvant Radiotherapy | |
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism | |
The nucleocapsid domain of Gag is dispensable for actin incorporation into HIV-1 and for association of viral budding sites with cortical F-actin. | |
Overexpression of the Interferon-Inducible Isoform 4 of Dissects the Entry Route of Enveloped Viruses and Demonstrates that HIV Enters Cells via Fusion at the Plasma Membrane | |
Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor SAMHD1 and the toxicity factor Top2β | |
Quantitation of endogenous nucleoside triphosphates and nucleosides in human cells by liquid chromatography tandem mass spectrometry | |
A quantitative measure for alterations in the actin cytoskeleton investigated with automated high-throughput microscopy | |
Reply to "Can HIV-1 entry sites be deduced by comparing bulk endocytosis to functional readouts for viral fusion?". | |
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy | |
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites | |
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies | |
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies | |
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1. |